Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

19 resultsUpdated October 23, 2026
1

Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution

Environmental Toxicology and Pharmacology 108 (2024)

Patrik Olekšák; Eugenie Nepovimová; Marián Valko; Saleh Hamad Alwasel; Suliman Yousef Alomar; Kamil Kuča

3

Codeine and Tramadol Use in Athletes: A Potential for Abuse

Frontiers in Pharmacology 12 (2021)

Thomas Zandonai; Mónica Escorial; Ana María Peiró

4

Annual banned‐substance review: analytical approaches in human sports drug testing

Drug Testing and Analysis 9(1) (2016)

Mario Thevis; Tiia Kuuranne; Hans Geyer; Wilhelm Schänzer

5

Case Report: A case study of positive doping control by animal-to-human drug transfer after an athlete administered medicine in spray format, containing clostebol acetate, to a pet dog

Frontiers in Sports and Active Living 6 (2024)

Andrzej Pokrywka; Dariusz Sitkowski; Olga Surała; Laurie Gheddar; Pascal Kintz

6

A hierarchical 3D camellia-like molybdenum tungsten disulfide architectures for the determination of morphine and tramadol

Microchimica Acta 187(5) (2020)

Somayeh Mohammadi; Mohammad Ali Taher; Hadi Beitollahi

7

Anaesthesia for elite athletes

European Journal of Anaesthesiology 39(10) (2022)

Bram Bourgonjon; Kris Vermeylen; Niek Tytgat; Patrice Forget

8

Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone

Drug Testing and Analysis 10(4) (2017)

Mikael Lehtihet; Alexander Andersson; Annica Börjesson; Jenny Jakobsson Schulze; Anders Rane; Magnus Ericsson; Lena Ekström

9

Pharmacogenomics as a Tool in Addressing Genetic VariationDependent Adverse Drug Reactions

Dutse Journal of Pure and Applied Sciences 10(1b) (2024)

Oluchukwu Ogechukwu Anunobi

10

Analytical True Positive

Elsevier eBooks (2019)

Amitava Dasgupta

11

Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan

Clinical Psychopharmacology and Neuroscience 15(3) (2017)

Giulia Milano; Werner Maria Natta; Alfredo Bello; Antonietta Martelli; Francesca Mattioli

12

Effect of non‐prohibited drugs on the phase II metabolic profile of morphine. An in vitro investigation for doping control purposes

Drug Testing and Analysis 10(6) (2017)

Gabriella Ambrosio; Xavier de la Torre; Monica Mazzarino; Maria Kristina Parr; Francesco Botrè

13

An Overview of Performance Enhancing Drugs (PED’s) in Sports and WADA

Journal of Young Pharmacists 11(4) (2019)

Karri Sowjanya; Chandrashekaran Girish

14

Morphine/codéine dans les urines de sportifs : quels ratios au cours des contrôles demandés par l’Agence française de lutte contre le dopage (AFLD) ?

Annales de Toxicologie Analytique 28(2) (2016)

Nathalie Méchin; E. Cerpolini; M. Conjeaud; M. Fernandes; A. Molina; Antoine Coquerel

16

Integrating pharmacogenetics in sport medicine: enhancing treatment precision and preventing unintentional doping violation

Pharmacogenetics and Genomics 35(5) (2025)

Guillaume Drevin; Marie B Briet; Chadi Abbara

17

Mass Spectrometry-Based Anti-Doping Analysis: A Critical Review of Emerging Analytical and Sample Pretreatment Strategies

Critical Reviews in Analytical Chemistry (2026)

Dnyaneshwar Maykar; Pratik Vilas Gore; Suraj R. Chaudhari; Pramod Kumar

18

Unlocking Performance: Pharmacogenomic Insights for Athletes

Sports Medicine International Open 10(CP) (2026)

Kristal Potter; Jessica Beal-Stahl; Megan Luaces; Kevin Chin; Anam F. Ismail; Courtney Guerra

19

Intra‐Individual Variability of Blood and Urinary Steroid Markers and the Response to Codeine Intake in Healthy Men and Women

Drug Testing and Analysis (2026)

Alexander Andersson; Basam Yousif; Anton Pohanka; Annica Börjesson; Mikael Lehtihet; Lena Ekström